In a tense Senate Finance Committee hearing that stretched across thirteen minutes of pointed interrogation, Democratic Senator Ron Wyden of Oregon delivered a devastating assessment of four Trump administration nominees, culminating in a single sharp line that cut through months of bureaucratic evasion: "There is no there there."
The hearing, convened to consider nominees for some of the most consequential positions in American health care and tax policy, unfolded against a backdrop of mounting national crisis. The country is currently grappling with the largest measles outbreak since the widespread availability of the vaccine, a development that has intensified scrutiny of the administration's health leadership.
At the center of the storm sits Chris Clomp, nominated to serve as Robert Kennedy Jr.'s second-in-command at the Department of Health and Human Services. Clomp has already been performing the role unofficially for several months, a fact that Democrats repeatedly emphasized as evidence that promises made to the committee have gone unfulfilled.
The Prescription Drug Deal That Never Materialized
Senator Wyden opened his remarks by directing attention to what he characterized as a pattern of broken commitments. In April, committee members formally requested that Robert Kennedy produce the details of Trump's prescription drug deals. Kennedy assured the committee that Clomp would help facilitate that disclosure.
Five months later, according to Wyden, the committee has received nothing but "lame excuses and delays." The senator's frustration was palpable as he noted that any administration genuinely committed to helping Americans afford their medications would be eager to publicize such achievements.
Instead, Wyden argued, the Trump plan on drug prices amounts to a simple proposition: "Trust me and trust Big Pharma." He pointed to a recent Freedom of Information Act request that revealed portions of the agreements, which showed fast-track approval for new drugs and tariff exemptions for pharmaceutical companies.
What those disclosures notably lacked, Wyden emphasized, was any evidence that patients or taxpayers are receiving lower prices. Financial analysts have concluded that the details are immaterial to Big Pharma stock prices, a finding that led Wyden to a blunt conclusion: "These deals are a fraud."
The Medicare Hypocrisy Exposed
Shifting to what he called the leadership question on Medicare, Wyden quoted Clomp's own words back to him. During meetings with committee staff, Clomp had stated, "People pay into Medicare their whole lives. It's the great social contract."
Yet Wyden revealed that Clomp is the third Trump nominee to come before the committee who has manipulated tax payments to avoid contributing to Social Security or Medicare in at least two of the last several years. A federal court recently ruled that this tax maneuver is actually illegal.
The irony was not lost on the senator. Clomp, who champions good stewardship in government, has set what Wyden described as a poor example for someone seeking to lead the very program he has avoided supporting through his own tax contributions.
The Vaccine Crisis and Kennedy's False Claims
Perhaps the most emotionally charged portion of Wyden's remarks centered on vaccines. He noted that while Clomp speaks of following evidence, the leadership of Robert Kennedy at HHS has demonstrated precisely the opposite approach.
Wyden cited Kennedy's continued "lies and fear-mongering," including the outlandish claim that the measles vaccine contains aborted fetal debris. Later this week, Kennedy is scheduled to speak before the largest anti-vaccine group in America.
Meanwhile, children in America are dying because vaccination rates are dropping. Wyden expressed disbelief that the nation finds itself in the midst of a record-setting outbreak of a disease that was once considered eradicated.
The senator also highlighted that this crisis is unfolding alongside the largest cut to federal health spending in American history. One trillion dollars has been slashed from Medicaid, millions have lost their insurance coverage, and health care premiums have risen dramatically.
The Exclusive Club and the Price of Access
In meetings with committee staff, Clomp attempted to present himself as fresh leadership that would restore integrity to the department. Wyden found this characterization difficult to accept.
He noted that Clomp has already been on the job for months and is a member of what Wyden described as an exclusive club where a membership fee of up to $500,000 grants access to MAGA insiders. The implication was clear: this is not an outsider bringing reform, but an insider embedded in the very system he claims to want to change.
Questionable Independence at the Research Office
Wyden then turned to Gigi Bai, nominated to be assistant secretary for planning and evaluation, essentially the research arm of the department responsible for independent analysis to inform federal policy making.
Like Clomp, Bai has already been serving in an acting capacity. Several reports issued by the research office under her leadership have called her independence into question.
Two studies about health care coverage losses relied on what Wyden characterized as shoddy analysis from an arch-conservative think tank, seemingly designed to downplay how many Americans would be harmed by the Trump cuts. If confirmed, Wyden warned, Bai's history suggests she will continue helping Trump eradicate independent oversight of his administration.
The IRS and the Corruption Epicenter
The senator next addressed Jim Gadwood, nominated to be chief counsel at the IRS, which Wyden described as an epicenter of corruption. He referenced what he called the sweetheart immunity deal that Trump secured, noting that currently everyone in America is subject to a tax audit except the president and his family.
This immunity deal, Wyden argued, is a flagrant abuse of power that sets a dangerous precedent. Gadwood is currently employed by a law firm that represents Donald Trump's holding company, yet he has refused to disclose whether the president or his family are clients.
Past nominees have consistently been willing to disclose their client lists and recuse themselves from issues relating to Trump. Gadwood, according to Wyden, has done neither. Meanwhile, the administration has weaponized the IRS, illegally sharing hundreds of thousands of taxpayers' private information with ICE as part of Trump's anti-immigrant agenda.
The Tax Court Nominee Who Refused to Answer
Finally, Wyden addressed Andrew De Mello, nominated to be a tax court judge. According to court records, De Mello approved a memo that allowed the IRS to begin sharing sensitive taxpayer information with ICE.
He has outright refused to answer some of the committee's vetting questions. Every nominee who comes before the committee must commit to responding in writing to any request made by a member. De Mello failed to do so, leading Wyden to declare that his presence at the hearing was not legitimate.
The Pattern of Obstruction and Misrepresentation
Throughout his remarks, Wyden emphasized that none of the nominees being considered have shown the ability or desire to rein in the lawlessness of the Trump agenda, particularly the dangerous aspects he outlined.
He noted that the committee was voting on four Trump nominees who will operate at the heart of American health care and tax policy. Unfortunately, he said, these nominees have displayed the same pattern of obstruction and misrepresentation seen so often before.
On the drug deals, Wyden made clear he would continue fighting to impede Clomp's nomination until the details are made public. He characterized the agreements as chock-full of goodies for Big Pharma while missing any evidence that patients and taxpayers are getting lower prices.
Regarding vaccines, Wyden reminded the committee that Robert Kennedy had told the Finance Committee fewer than 37 times that he would do nothing as HHS secretary that makes it difficult or discourages people from taking vaccines. Wyden called that statement a lie, one that Republican colleagues swallowed when they voted to confirm him.
Clomp, Wyden argued, is complicit in these lies despite trying very hard to convince people otherwise. The CDC had been refusing to provide access to COVID vaccines under the Vaccine for Children program until yesterday, a vital program that protects millions of low-income kids.
The Fall Season Warning
As the country enters the fall season, Wyden issued a warning that he will be watching closely for more games that delay or deny vaccines to those who need them.
He also noted that the federal court ruling on the tax maneuver used by Clomp, if upheld, should require Clomp, as well as Secretary Becerra and CMS Administrator Azar, to pay back the taxes they owed to the American people.
On Bai, Wyden pointed out that multiple reports containing false information were published under her watch. This week, JD Vance, flanked by Oz and Clomp, used one of those faulty reports to justify colluding with insurance companies to kick 760,000 low- and middle-income Americans off their health insurance.
Wyden described this as one big red flag that a nominee is going to prioritize the Trump administration's political narrative over honestly examining the realities of what Americans are experiencing with their health care.
The IRS Conflict of Interest
Regarding the IRS chief counsel nominee, Wyden expressed grave concern about the administration's complete disregard for the law on tax matters relating to privacy and political interference.
The nominee works for a law firm that represents Donald Trump's private company. When asked whether he represented Trump's company, he refused to answer. Wyden asked him at the hearing and received the same non-answer. He met with him in his office and still received no answer.
That level of secrecy and obstruction, at a time when the IRS is trying to give the president a corrupt immunity deal, represents what Wyden called a whopping conflict of interest that should be disqualifying for a position of such import.
Conclusion: A Failure to Follow the Law
Wyden concluded by stating that neither of the tax nominees have convinced him that they will follow the law ahead of orders handed down by Donald Trump, Scott Bessent, or Frank Pizzignano.
Americans expect those who administer the tax code to be fair and impartial. The current administration, Wyden declared, fails and fails to meet that standard.
The hearing underscored the deep partisan divide over the direction of federal health and tax policy. Democrats on the committee have made clear they will continue to demand transparency and accountability from nominees they believe are more loyal to the president than to the American people.
For Republicans, the focus remains on confirming the president's picks and advancing an agenda they argue will cut government waste and restore accountability. Whether Wyden's sharp words will translate into any change in the nominees' fates remains to be seen.
0 Comments